European Commission Approves Roche’s Vabysmo for Retinal Vein Occlusion
The European Commission has approved Roche’s Vabysmo® (faricimab) for the treatment of macular edema secondary to retinal vein occlusion (RVO), including both branch and central retinal vein occlusion (BRVO and CRVO). This approval is a significant …